化学科研者一站式服务平台


  • Omecamtiv mecarbil

    methyl 4-[[2-fluoro-3-[(6-methylpyridin-3-yl)carbamoylamino]phenyl]methyl]piperazine-1-carboxylate

化合物简介

CK 1827452 is a promising new drug in systolic heart failure. It accelerates the transition of myosin into the force-generating state without affecting cardiac myocyte calcium homeostasis. CK 1827452 increases cardiac function by increasing the duration of ejection without changing the rates of contraction.

基本信息

CAS:873697-71-3
中文别名
英文别名:methyl 4-(2-fluoro-5-(3-(6-methylpyridin-3-yl)ureido)benzyl)piperazine-1-carboxylate;methyl 4-(2-fluoro-3-(3-(6-methylpyridin-3-yl)ureido)benzyl)piperazine-1-carboxylate;methyl 4-[(2-fluoro-3-{[(6-methyl(3-pyridyl))amino]carbonylamino}phenyl)methyl]piperazinecarboxylate;Omecamtiv mecarbil (USAN/INN);Omecamtiv mecarbil;
分子式:C20H24FN5O3
分子量:401.435
精确质量:401.186
Psa:90.29
Logp:3.0195

编号系统

MDL号:MFCD18633260

物化性质

密度:1.344 g/cm3
沸点:456.78ºC at 760 mmHg
闪点:230.052ºC

安全信息

生产方法及用途

合成路线

上游原料

下游产品

图谱

1H NMR : Predict


13C NMR : Predict


加载中...